NEPHROS, INC. Other Nonoperating Expense
NEPHROS, INC. (NEPH) reported Other Nonoperating Expense of $78.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2026-03-12
- NEPHROS, INC. other nonoperating expense for the quarter ending 2023-03-31 was $11.00K, a 22.22% increase year-over-year.
- NEPHROS, INC. other nonoperating expense for the quarter ending 2022-03-31 was $9.00K.
- NEPHROS, INC. other nonoperating expense for fiscal 2025 was $78.00K, a 680.00% increase from fiscal 2024.
- NEPHROS, INC. other nonoperating expense for fiscal 2024 was $10.00K, a 77.27% decline from fiscal 2023.
- NEPHROS, INC. other nonoperating expense for fiscal 2023 was $44.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 12 month |
|---|---|---|
| 2025-12-31 | $78.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $10.00K 10-K · filed 2026-03-12 | |
| 2023-12-31 | $44.00K 10-K · filed 2025-03-24 | |
| 2023-03-31 | $11.00K 10-Q · filed 2023-05-10 | |
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |